Global EditionASIA 中文雙語(yǔ)Fran?ais
    World
    Home / World / Middle East

    Chinese shots turn tide in Middle East

    By JAN YUMUL in Hong Kong | China Daily | Updated: 2021-03-11 10:29
    Share
    Share - WeChat
    A booth displaying a coronavirus vaccine candidate from China National Pharmaceutical Group (Sinopharm), is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the COVID-19 outbreak, in Beijing, in this September 4, 2020 file photo. [Photo/Agencies]

    Shipments of vital jabs across region fuel optimism for return to normalcy

    China's COVID-19 vaccines have come a long way in the Middle East. They were the first of the global offerings to secure authorization for emergency use there and one of them led a poll as the vaccine of choice in the region. To top that off, they have scored high on efficacy ratings.

    An online survey by data analytics firm YouGov has indicated that over 80 percent of those vaccinated against the coronavirus in the United Arab Emirates had opted for a Chinese-developed vaccine from Sinopharm.

    In the survey commissioned by G42 Healthcare, a subsidiary of Abu Dhabi-based technology company Group 42, 76 percent of the respondents said they believe the COVID-19 vaccines will bring life back to normal within a year.

    The UAE approved the Sinopharm shots on Dec 9, after declaring an 86 percent efficacy rate for the jabs.

    The YouGov-G42 survey, which started in January, was carried out to determine people's attitudes to COVID-19 vaccines. It found that safety and efficacy were the main factors that influenced their decisions.

    A total of 1,011 people were polled in the UAE for the survey, with the participants expressing optimism that the vaccines will help turn the tide in the public health crisis.

    The Abu Dhabi-based English daily The National reported on Tuesday that some people in the UAE who did not develop antibodies against COVID-19 could take a booster shot or a third dose of the Sinopharm vaccine, which is available for free across the country.

    High efficacy proved

    Chinese vaccines could find even more takers in the region in the coming months after Turkish researchers announced last week that a COVID-19 vaccine developed by China's Sinovac Biotech had an efficacy of 83.5 percent, based on phase III trials.

    The results unveiled by Ankara's Hacettepe University came after trials involving 10,216 participants aged 18-59.

    The UAE vaccine survey revealed that safety remained the top determinant for people considering vaccination, with 52 percent of respondents citing safety and efficacy as the key motivators. This was followed by perceptions of a lack of major side effects, at 50 percent, on a list of factors.

    Arab League Assistant Secretary-General Hossam Zaki, who received a batch of Sinopharm's COVID-19 vaccines in Cairo last week, said China's medical assistance to the Pan-Arab body "will effectively enhance the anti-epidemic capabilities of the Arab world", the Xinhua News Agency reported.

    Michael Stanat, vice-president of global operations at SIS International Research, a consulting firm headquartered in New York, said: "Chinese vaccines position China as a global healthcare leader and innovator alongside the likes of the US and Europe."

    For Martin Lush, global vice-president at NSF International, a US-based public health and safety organization, said the global elimination of the virus will not happen and that we "must learn to live with it, just like we do (with) flu".

    As of Monday, the UAE had administered 6,287,751 doses of COVID-19 vaccines, with a distribution rate of 63.57 doses per 100 people.

    The UAE's National Emergency Crisis and Disaster Management Authority noted on Feb 23 that authorities had noticed a gradual decrease in registered COVID-19 cases.

    "We confirm the effectiveness and safety of the vaccines that were approved in the country," it said.

    Most Viewed in 24 Hours
    Top
    BACK TO THE TOP
    English
    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
    日韩va中文字幕无码电影| 国产中文在线亚洲精品官网| 中文字幕视频一区| HEYZO无码综合国产精品| 亚洲av午夜国产精品无码中文字| Aⅴ精品无码无卡在线观看| 无码av高潮喷水无码专区线| 中文无码熟妇人妻AV在线 | 久久久无码精品午夜| 综合久久久久久中文字幕亚洲国产国产综合一区首 | 中文字幕无码精品亚洲资源网久久| 亚洲一本大道无码av天堂| 精品国产a∨无码一区二区三区| 国产成年无码AV片在线韩国 | 欧美中文在线视频| 亚洲成a人无码av波多野按摩| 久久AV高清无码| 精品亚洲AV无码一区二区三区| 一区二区中文字幕| 日本中文字幕在线| 无码av中文一二三区| 欧洲人妻丰满av无码久久不卡| 在线观看片免费人成视频无码| 中文字幕亚洲综合精品一区| 中文成人无码精品久久久不卡| 日韩人妻无码一区二区三区99| 亚洲精品无码mv在线观看网站| 日韩精品无码免费专区网站| 中文无码喷潮在线播放| 玖玖资源站中文字幕在线| 最近最新中文字幕高清免费| 最近2019中文字幕| 最近中文国语字幕在线播放视频| 日韩欧美中文在线| 日韩精品一区二三区中文| 无码人妻一区二区三区一| 蜜桃AV无码免费看永久| 亚洲精品中文字幕无码蜜桃 | 精品无码AV一区二区三区不卡| 性无码专区无码片| 国产爆乳无码一区二区麻豆|